US Stocks Mixed; Initial Jobless Claims Fall

Author: Avi Kapoor | July 10, 2025 09:46am

U.S. stocks traded mixed this morning, with the Dow Jones index gaining around 100 points on Thursday.

Following the market opening Thursday, the Dow traded up 0.24% to 44,564.14 while the NASDAQ declined 0.44% to 20,520.54. The S&P 500 also fell, dropping, 0.09% to 6,257.81.

Check This Out: Top 2 Tech Stocks That May Plunge This Month

Leading and Lagging Sectors

Health care shares jumped by 0.9% on Thursday.

In trading on Thursday, communication services stocks dipped by 1.2%.

Top Headline

U.S. initial jobless claims declined by 5,000 from the previous week to 227,000 in the first week of July, compared to market estimates of 235,000.

Equities Trading UP
           

• Above Food Ingredients Inc. (NASDAQ:ABVE) shares shot up 330% to $1.53 on continued strength following its merger agreement with Palm Global on Monday.
• Shares of DallasNews Corporation (NASDAQ:DALN) got a boost, surging 218% to $13.55 after the company announced Hearst will acquire it for $14 per share.
• BIT Mining Limited (NASDAQ:BTCM) shares were also up, gaining 117% to $5.34 after the company announced it plans an investment up to $300 million to expand into the Solana ecosystem.

Equities Trading DOWN

• Mereo BioPharma Group plc (NASDAQ:MREO) shares dropped 35% to $1.9150. Ultragenyx Pharmaceutical and Mereo BioPharma on Wednesday announced that the randomized, placebo-controlled Phase 3 portion of the Orbit study evaluating UX143 (setrusumab) in pediatric and young adult patients with osteogenesis imperfecta (OI) is progressing toward a final analysis around the end of the year, consistent with the original plan.
• Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) were down 27% to $30.11. Ultragenyx Pharmaceutical and Mereo BioPharma on Wednesday announced that the randomized, placebo-controlled Phase 3 portion of the Orbit study evaluating UX143 (setrusumab) in pediatric and young adult patients with osteogenesis imperfecta (OI) is progressing toward a final analysis around the end of the year, consistent with the original plan.
• CURRENC Group Inc. (NASDAQ:CURR) was down, falling 27% to $1.48 as the company announced the pricing of $60 million underwritten public offering at a price of $5/share.

Commodities

In commodity news, oil traded down 1.8% to $67.14 while gold traded up 0.1% at $3,322.90.

Silver traded up 0.8% to $36.930 on Thursday, while copper rose 1.8% to $5.5885.

Euro zone

European shares were mixed today. The eurozone's STOXX 600 rose 0.5%, while Spain's IBEX 35 Index fell 0.6%. London's FTSE 100 gained 1.1%, Germany's DAX 40 slipped 0.3% and France's CAC 40 gained 0.3% during the session.

Asia Pacific Markets

Asian markets closed mixed on Thursday, with Japan's Nikkei falling 0.44%, Hong Kong's Hang Seng gaining 0.57%, China's Shanghai Composite gaining 0.48% and India's BSE Sensex falling 0.41%.

Economics

U.S. initial jobless claims declined by 5,000 from the previous week to 227,000 in the first week of July, compared to market estimates of 235,000.

Now Read This:

• How To Earn $500 A Month From JPMorgan Stock Ahead Of Q2 Earnings

Photo via Shutterstock

Posted In: ABVE BTCM CURR DALN MREO RARE